Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Efficient location discovery
Tablet computer
Quantifying the risks of applications for mobile devices
Coreference resolution in an ambiguity-sensitive natural language processing system
Topology discovery, control channel establishment, and datapath provisioning within an aggregation network with centralized control
Mechanisms for marking the orientation of a sawed die
Systems and methods for image stream processing
  Randomly Featured Patents
Animated frog
Device for sealing container openings by applying stretch plastic film
Linearization of raster patterns in 2D optical scanners
Lenses, optical sources, and their couplings
Light emitting device and information processing apparatus
On-the-fly memory testing and automatic generation of bitmaps
System permitting channeling of drainage fluid
Multi-frequency eddy-current system and method
Rotating washer assembly
Method for filtering benzo-a-pyrene from a gas stream